| Summary of Net Revenue, Cost of Sales, Depreciation and Amortization, Operating Profit, and Interest Expense and Assets by Segment |
The following table shows, by segment: net revenue, cost of sales, depreciation and amortization, operating profit, and interest expense for the three months and six months ended May 31, 2021 and May 31, 2020:
|
|
|
For the three
months ended
May 31,
2021
|
|
|
For the three
months ended
May 31,
2020
|
|
|
Net revenue
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$
|
7,158,886
|
|
|
$
|
7,600,902
|
|
|
PrepaCyte®-CB
|
|
|
—
|
|
|
|
57,300
|
|
|
Public cord blood banking
|
|
|
46,309
|
|
|
|
213,642
|
|
|
Total net revenue
|
|
$
|
7,205,195
|
|
|
$
|
7,871,844
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$
|
1,869,769
|
|
|
$
|
1,966,441
|
|
|
PrepaCyte®-CB
|
|
|
41,203
|
|
|
|
32,014
|
|
|
Public cord blood banking
|
|
|
311,699
|
|
|
|
482,088
|
|
|
Total cost of sales
|
|
$
|
2,222,671
|
|
|
$
|
2,480,543
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$
|
260,226
|
|
|
$
|
36,408
|
|
|
PrepaCyte®-CB
|
|
|
6,894
|
|
|
|
6,895
|
|
|
Public cord blood banking
|
|
|
302
|
|
|
|
—
|
|
|
Total depreciation and amortization
|
|
$
|
267,422
|
|
|
$
|
43,303
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$
|
2,308,856
|
|
|
$
|
2,002,877
|
|
|
PrepaCyte®-CB
|
|
|
(48,097
|
)
|
|
|
17,984
|
|
|
Public cord blood banking
|
|
|
(265,691
|
)
|
|
|
(268,675
|
)
|
|
Total operating income
|
|
$
|
1,995,068
|
|
|
$
|
1,752,186
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$
|
341,390
|
|
|
$
|
365,371
|
|
|
PrepaCyte®-CB
|
|
|
—
|
|
|
|
—
|
|
|
Public cord blood banking
|
|
|
—
|
|
|
|
—
|
|
|
Total interest expense
|
|
$
|
341,390
|
|
|
$
|
365,371
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the six
months ended
May 31,
2021
|
|
|
For the six
months ended
May 31,
2020
|
|
|
Net revenue
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$
|
13,897,517
|
|
|
$
|
15,007,190
|
|
|
PrepaCyte®-CB
|
|
|
38,000
|
|
|
|
117,707
|
|
|
Public cord blood banking
|
|
|
130,295
|
|
|
|
367,721
|
|
|
Total net revenue
|
|
$
|
14,065,812
|
|
|
$
|
15,492,618
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$
|
3,509,784
|
|
|
$
|
4,021,515
|
|
|
PrepaCyte®-CB
|
|
|
76,084
|
|
|
|
73,131
|
|
|
Public cord blood banking
|
|
|
649,000
|
|
|
|
889,041
|
|
|
Total cost of sales
|
|
$
|
4,234,868
|
|
|
$
|
4,983,687
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$
|
274,594
|
|
|
$
|
73,735
|
|
|
PrepaCyte®-CB
|
|
|
13,789
|
|
|
|
13,789
|
|
|
Public cord blood banking
|
|
|
302
|
|
|
|
—
|
|
|
Total depreciation and amortization
|
|
$
|
288,685
|
|
|
$
|
87,524
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$
|
3,801,209
|
|
|
$
|
3,492,424
|
|
|
PrepaCyte®-CB
|
|
|
(51,873
|
)
|
|
|
30,379
|
|
|
Public cord blood banking
|
|
|
(519,007
|
)
|
|
|
(521,547
|
)
|
|
Total operating income
|
|
$
|
3,230,329
|
|
|
$
|
3,001,256
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$
|
621,609
|
|
|
$
|
730,670
|
|
|
PrepaCyte®-CB
|
|
|
—
|
|
|
|
—
|
|
|
Public cord blood banking
|
|
|
—
|
|
|
|
—
|
|
|
Total interest expense
|
|
$
|
621,609
|
|
|
$
|
730,670
|
|
|
|
|
|
|
|
|
|
|
|
The following table shows the assets by segment as of May 31, 2021 and November 30, 2020:
|
|
|
As of
May 31,
2021
|
|
|
As of
November 30,
2020
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$
|
46,465,499
|
|
|
$
|
34,215,780
|
|
|
PrepaCyte®-CB
|
|
|
283,830
|
|
|
|
302,683
|
|
|
Public cord blood banking
|
|
|
11,569,083
|
|
|
|
11,681,631
|
|
|
Total assets
|
|
$
|
58,318,412
|
|
|
$
|
46,200,094
|
|
|